MITRE: No Benefit for Continuous Glucose Monitoring Devices

2007 ◽  
Vol 7 (6) ◽  
pp. 12-20
Author(s):  
W. Alexander ◽  
S. Newman
Keyword(s):  
Continuous Glucose Monitoring ◽  
Glucose Monitoring ◽  
Monitoring Devices

scholarly journals Caution is required for the evaluation of the accuracy of continuous glucose monitoring devices

2019 ◽  
Vol 11 (1) ◽  
pp. 255-255 ◽  
Author(s):  
Yushi Hirota ◽  
Masao Toyoda ◽  
Takashi Murata ◽  
Junnosuke Miura
Keyword(s):  
Continuous Glucose Monitoring ◽  
Glucose Monitoring ◽  
Monitoring Devices

scholarly journals Potentialities of modern glucose monitoring devices during pregnancy

2020 ◽  
Vol 4 (6) ◽  
pp. 352-357
Author(s):  
F.O. Ushanova ◽  
◽  
T.Yu. Demidova ◽  
Keyword(s):  
Gestational Diabetes ◽  
Pregnant Women ◽  
Carbohydrate Metabolism ◽  
Continuous Glucose Monitoring ◽  
Glucose Monitoring ◽  
Nocturnal Hypoglycemia ◽  
Glucose Levels ◽  
Monitoring Technologies ◽  
Diabetes Gestational ◽  
Monitoring Devices

Currently, the management of pregnant women with carbohydrate metabolism disorders is challenging due to the high risk of unfavorable events both for the mother and the child even in insignificant deviations from the target value. In addition to the conventional methods of self-monitoring, continuous glucose monitoring (CGM) is an important tool to control diabetes. CGM in pregnant women provides the detailed information on the type and trends of the changes in blood glucose levels and the fluctuations of glucose levels and also identifies the episodes of latent nocturnal hypoglycemia and postprandial hyperglycemia. The analysis of CGM data allows for correcting insulin therapy, taking a decision on its initiation, and modifying diet and exercise plan. Multiple studies demonstrate the efficacy of CGM in terms of compensating manifest diabetes. As to gestational diabetes, the eligibility of modern glucose monitoring technologies for the prevention of various complications is still controversial. Further studies on the potential use of these devices in gestational diabetes could provide a basis for increasing their application in routine clinical practice. This will improve the management of pregnant women with carbohydrate metabolism disorders.KEYWORDS: diabetes, gestational diabetes, continuous glucose monitoring, flash monitoring, pregnancy, macrosomia, self-monitoring.FOR CITATION: Ushanova F.O., Demidova T.Yu. Potentialities of modern glucose monitoring devices during pregnancy. Russian Medical Inquiry. 2020;4(6):352–357. DOI: 10.32364/2587-6821-2020-4-6-352-357.

scholarly journals Real-World Hypoglycemia Avoidance With a Predictive Low Glucose Alert Does Not Depend on Frequent Screen Views

2019 ◽  
Vol 14 (1) ◽  
pp. 83-86 ◽  
Author(s):  
Sarah Puhr ◽  
Mark Derdzinski ◽  
Andrew Scott Parker ◽  
John B. Welsh ◽  
David A. Price
Keyword(s):  
Continuous Glucose Monitoring ◽  
Glucose Monitoring ◽  
Mobile App ◽  
Convenience Sample ◽  
Minute Interval ◽  
Patients With Diabetes ◽  
Low Glucose ◽  
Device Interaction ◽  
Mean Glucose ◽  
Monitoring Devices

Background: Frequent real-time continuous glucose monitoring (rtCGM) data viewing has been associated with reduced mean glucose and frequent scanning of an intermittently scanned continuous glucose monitoring (isCGM) system has been associated with reduced hypoglycemia for patients with diabetes. However, requiring patients to frequently interact with their glucose monitoring devices to detect actual or impending hypoglycemia is burdensome. We hypothesized that a predictive low glucose alert, which forecasts glucose ≤55 mg/dL within 20 minutes and is included in a new rtCGM system, could mitigate hypoglycemia without requiring frequent device interaction. Methods: We analyzed estimated glucose values (EGVs) from an anonymized convenience sample of 15,000 patients who used Dexcom G6 (Dexcom, Inc, San Diego, CA, USA) and its mobile app for at least 30 days with or without the “Urgent Low Soon” alert (ULS) enabled. Screen view frequency was determined as the frequency with which the trend screen was accessed on the app. Multiple screen views within any 5-minute interval were counted as one. Hypoglycemia exposure for patients in the top and bottom quartiles of screen view frequency (>8.25 and <3.30 per day, respectively) was calculated as the percentage of EGVs below various thresholds. Results: Over 93% of users enabled the ULS alert; its use was associated with significantly reduced hypoglycemia <55 and <70 mg/dL, independent of screen view frequency. Conclusion: Use of the G6 ULS alert may disencumber rtCGM users by promoting significant reductions in hypoglycemia without requiring frequent device interactions.

scholarly journals Continuous Glucose Monitoring Devices: Past, Present, and Future Focus on the History and Evolution of Technological Innovation

2020 ◽  
pp. 193229681989939 ◽  
Author(s):  
Olesya Didyuk ◽  
Nicolas Econom ◽  
Angelica Guardia ◽  
Kelsey Livingston ◽  
Ulrike Klueh
Keyword(s):  
Quality Of Life ◽  
Technological Innovation ◽  
Continuous Glucose Monitoring ◽  
Glucose Control ◽  
Diabetes Management ◽  
Glucose Monitoring ◽  
Glucose Sensors ◽  
Implantable Sensor ◽  
Monitoring Devices

The concept of implantable glucose sensors has been promulgated for more than 40 years. It is now accepted that continuous glucose monitoring (CGM) increases quality of life by allowing informed diabetes management decisions as a result of more optimized glucose control. The focus of this article is to provide a brief overview of the CGM market history, emerging technologies, and the foreseeable challenges for the next CGM generations as well as proposing possible solutions in an effort to advance the next generation of implantable sensor.

scholarly journals Measures of Accuracy for Continuous Glucose Monitoring and Blood Glucose Monitoring Devices

2018 ◽  
Vol 13 (3) ◽  
pp. 575-583 ◽  
Author(s):  
Guido Freckmann ◽  
Stefan Pleus ◽  
Mike Grady ◽  
Steven Setford ◽  
Brian Levy
Keyword(s):  
Blood Glucose ◽  
Continuous Glucose Monitoring ◽  
Measurement Accuracy ◽  
Glucose Monitoring ◽  
Blood Glucose Monitoring ◽  
Glucose Measurement ◽  
Bias Analysis ◽  
Patients With Diabetes ◽  
Monitoring Devices ◽  
Error Grid

Currently, patients with diabetes may choose between two major types of system for glucose measurement: blood glucose monitoring (BGM) systems measuring glucose within capillary blood and continuous glucose monitoring (CGM) systems measuring glucose within interstitial fluid. Although BGM and CGM systems offer different functionality, both types of system are intended to help users achieve improved glucose control. Another area in which BGM and CGM systems differ is measurement accuracy. In the literature, BGM system accuracy is assessed mainly according to ISO 15197:2013 accuracy requirements, whereas CGM accuracy has hitherto mainly been assessed by MARD, although often results from additional analyses such as bias analysis or error grid analysis are provided. The intention of this review is to provide a comparison of different approaches used to determine the accuracy of BGM and CGM systems and factors that should be considered when using these different measures of accuracy to make comparisons between the analytical performance (ie, accuracy) of BGM and CGM systems. In addition, real-world implications of accuracy and its relevance are discussed.

PDB40 Eliciting Patient Preferences for Continuous Glucose Monitoring Devices in Type 1 Diabetes

2021 ◽  
Vol 24 ◽  
pp. S85
Author(s):  
K. Hannah ◽  
R. Lich ◽  
K. Nair ◽  
H.D. Anderson ◽  
S. Ellis ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Continuous Glucose Monitoring ◽  
Patient Preferences ◽  
Glucose Monitoring ◽  
Monitoring Devices

scholarly journals Manufacturing Process Changes and Reduced Skin Irritations of an Adhesive Patch Used for Continuous Glucose Monitoring Devices

2017 ◽  
Vol 12 (3) ◽  
pp. 725-726 ◽  
Author(s):  
Vitaliy Gisin ◽  
Anna Chan ◽  
John B. Welsh
Keyword(s):  
Continuous Glucose Monitoring ◽  
Manufacturing Process ◽  
Lower Risk ◽  
Skin Irritation ◽  
Glucose Monitoring ◽  
Assembly Process ◽  
Adhesive Patch ◽  
Ethyl Cyanoacrylate ◽  
Monitoring Devices ◽  
Sensor Assembly

Adhesives used for continuous glucose monitoring (CGM) devices can cause skin irritations, which sometimes lead to abandonment of the therapy. A previous sensor manufacturing process involved two separate adhesives—one applied to the skin-facing surface of the fabric patch, and a second, ethyl cyanoacrylate-based adhesive, which secured the plastic transmitter housing to the superficial side of the patch. Our current process for attaching the transmitter housing to the fabric patch uses heatstaking, wherein the housing is heated and pressed against the patch with a specialized assembly apparatus. Heatstaking simplifies the sensor assembly process and obviates the need for the second adhesive, which may lead to lower risk of skin irritation(s) in some patients.

Sign in / Sign up

Export Citation Format

Share Document